Clinical Trials · NCT06611904
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Attikon Hospital
- Enrollment
- 60
- Start date
- Feb 2018
- Locations
- 1 site, Greece
- Primary endpoint
- UACR